Experience with ciclesonide in patients with mild persistent bronchial asthma
BARTOŠÍKOVÁ L., NEČAS J., FRÁŇA L.1, BARTOŠÍK T.2
Univerzita Palackého, Lékařská fakulta, Ústav fyziologie, Olomouc 1Dům zdraví, Velké Meziříčí 2Anesteziologicko-resuscitační klinika FN U sv. Anny v Brně |
|
Summary:
The study aimed to monitor the effectiveness and safety of the treatment with ciclesonide,
administered once a day in a 160 μg dose, over a 3-month period, to a group of 100 patients
diagnosed with mild persistent bronchial asthma with deterioration of problems after exercise. The
results of the study prove significant positive effects of the preparation used. A significant
improvement of FEV1 and PEF values was observed, as well as a statistically significant remission
of both day and nocturnal symptoms of the disease, a significantly lower consumption of shortacting
β2-sympathomimetics, and an improvement of all evaluated data relating to the quality of life
of the asthmatic patients. No adverse effects were registered.
Key words:
ciclesonide – inhaled corticosteroids – bronchial asthma
|